Product: Nucala (mepolizumab) Injection, 100 mg/mL Prefilled Syringe, Single-Dose, For subcutaneous use only, Rx Only, Manufactured by GlaxoSmithKline LLC, Philadelphia, PA 19112, Distributed by GlaxoSmithKline, Research Triangle Park, NC 27709, NDC 0173-0892-42.
Reason for recall: Temperature Abuse; Product stored and shipped outside of labeled storage requirements.
Recall initiated: 20190906
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated